Nevertheless, as the authors of the special articles in issue 37.1 showed, some progress is being made, and the basis for radical reform is being laid down.
Issue 37.2, which focused on Refinement, was organised by Michelle Hudson, in consultation with David Morton and Maggy Jennings. This is arguably the R where most has been achieved since the Three Rs concept was introduced in 1969 and the 1986 Act and new legislation in other countries came into force in the 1980s. The special articles supported Russell and Burch's contention that good science and good animal welfare must go hand in hand, but nobody foresaw the challenges to all of the Three Rs, not least to Refinement, that would result from the explosion in the use of genetically-modified animals, which took off in the 1990s and continues, virtually unchecked, today.
Issue 37.3 dealt with The Three Rs, and the opportunity was taken to reprint three articles from earlier issues of ATLA, by the founders of the concept themselves. These were a prefatory note to volume 23 (1995) , which marked FRAME's 25th anniversary and was a tribute to its founder, Dorothy Hegarty; Rex Burch's personal recollections, published in 1995, shortly before his death; and Bill Russell's First Annual FRAME Lecture (1999). The issue also included a reprinting of the Three Rs Declaration of Bologna (1999), and an article on the origins and early days of the Three Rs.
Issue 37.4, organised by Nirmala Bhogal, was concerned with Replacement -Focus on the Development of Therapeutics, which, as a number of the authors pointed out, is desperately needed, because of an ongoing decline in the introduction of new products, and the increasing rate of withdrawal of drugs which have been placed on the market, as a result of unacceptable adverse effects not detected during preclinical testing. The special articles dealt with some intriguing concepts, such as "changing the mindset", "a clinical trial in a test tube", "avoiding drug development mistakes early", and "the best model for humans is human".
Issue 37.5, on Replacement -Focus on In Silico Methods, was organised by Mark Cronin, and the special articles showed what remarkable progress is being made at the in chemico-in silico interface, in physiologically-based simulation modelling, and in the use of computers in drug discovery and safety evaluation. The other articles in this issue were also important, including one which focused on the importance of applicability domains for knowledge-based expert systems, and another on the use of mechanisms of action and modes of action in integrated testing strategies.
Issue 37.6, organised in consultation with Richard Clothier, is centred on Replacement -Focus on the Testing of Chemicals and Products, as seen from the perspectives of a company with products to sell and consumers to protect. The special articles go on to describe outstanding innovation in the design, development, validation and supply for use, of tests based on reconstituted human skin equivalents; the interactions of a contract in vitro test laboratory with its collaborators, customers and regulators; and the establishment and acceptance of non-animal tests for reproductive toxicology. In addition, FRAME's role in the development and practical application of the validation concept is also reviewed.
In addition to these six special issues, volume 37 of ATLA has included two important supplements. Despite all this effort and the encouragement that can be gleaned from it, the rate of progress is not fast enough, and far too many animals are still being used in pointless experiments based on entrenched and old-fashioned approaches. Part of the problem, as explained by Rodger Curren in this ATLA issue, 1 with reference to the use of non-animal tests in the chemical and product testing arena, is that: Although some companies have made tremendous contributions to reduce their animal use by adopting in vitro methods, there are still many other companies which have resisted making a change. These companies insist on the use of the traditional animal methods, in spite of the existence of validated in vitro methods. Whether this resistance to change is due to liability concerns, a general fear of change, ignorance of the availability of new methods, or just scientific inertia, is often unclear.
This problem is mirrored in basic research and in other areas of applied science where animals have traditionally been the tools of first resort. It was a problem with which Russell and Burch were familiar, as they said, In the course of this book, we have again and again encountered instances of long delay in the application of existing knowledge to the improvement of experimentation, and Delays of this kind may be regarded as a sort of inertia, or rigidity, the maintenance of a habit (positive or negative) long after information is available for its correction. 2 Even today, 50 years after the publication of The Principles, and despite the enormous contributions being made, practically, philosophically and ethically, by a dedicated small minority, the vast majority seem to be allowed to continue to do things as they have always done them. This is also despite the laws and regulations which should surely apply to everybody, and not just to those who voluntarily agree to obey them. Where are the politicians when they are needed, who should see to it that the laws that they enact are treated with respect and applied in the ways which were intended? 
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